Stanford PD Community Blog

Stanford Parkinson's Community
  • Home
You are here: Home / Support Groups - Meetings & Notes / PD, PSP, CBD, MSA Research Studies Recruiting NOW in Northern and Central California

PD, PSP, CBD, MSA Research Studies Recruiting NOW in Northern and Central California

April 6, 2014 By Parkinson's Community Help

Tulip flowerIt has been awhile since the Stanford APDA Parkinson’s Information & Referral Center published a list of all of the PD, MSA, PSP, or CBD research studies currently recruiting at non-profit institutions in Northern California.  Since April is Parkinson’s Awareness Month, we decided to compile the list below to encourage everyone in the wider community to participate in at least one of these studies!

As of today, there are research studies going on at four movement disorder centers in Northern and Central California:

  • Stanford University
  • The Parkinson’s Institute
  • University of California Berkeley
  • University of California Davis

These studies are recruiting those with:

  • Parkinson’s Disease
  • Multiple System Atrophy
  • Progressive Supranuclear Palsy
  • Corticobasal Degeneration
  • healthy control subjects
  • smell loss who do not have a Parkinson’s Disease diagnosis
  • a genetic mutation in the LRRK2 or SNCA gene
  • neurogenic orthostatic hypotension (NOH)

If you fall into one of those categories, keep reading and participate in at least one study, if you are able.  If you don’t know what MSA, PSP, CBD, LRRK2, SNCA, or NOH is, just skip the study.  If you don’t fall into one of those categories, consider registering at Fox Trial Finder (more info below). When we say “research study,” we are referring to:

  • clinical trials where there is an intervention tested – a drug, therapy, or experimental treatment
  • observational studies where participants are observed over time

We’ve provided brief info on the specific studies from four movement disorder centers that are actively recruiting below.Some movement disorder centers in Northern California ONLY allow their patients to participate in research studies. They don’t recruit from the wider community.  Such studies are NOT part of the list below. You can always search for actively-recruiting clinical trials by visiting clinicaltrials.gov.  There are many search options including a basic search (Parkinson’s and Stanford), advanced search (Recruitment: Open Studies recruiting; Conditions: Parkinson’s; State 1: United States/California; Location Terms: Stanford) or a combination of search terms including name of trial, name of sponsor, trials with results, etc.

Another resource, requiring pre-registration (with a name, email address, and password you choose), is Fox Trial Finder. Fox Trial Finder works like a dating website, where those in search of a trial and researchers in search of participants can find each other, communicate securely, and pre-screen for matches of interest.  Some of the research facilities do not have adequate staffing to enter all of their trials and all of the details of the participants being sought, so the information will not be as complete as on clinicaltrials.gov.

For good background on types of clinical trials, trial phases, why it is so important that more people volunteer for trails, etc, see this Michael J. Fox Foundation webpage.

Have fun participating in some research!

Check out the list below.

Robin
parkinsons.stanford.edu

 

Here’s what’s going on at a movement disorder center near you…

STANFORD UNIVERSITY


1-SU:  Development of multimodal imaging biomarkers for cognitive
dysfunction in Parkinson’s disease

Purpose:  Our goal is to better understand brain networks and biological markers associated with memory changes in Parkinson’s disease, and to find ways of detecting these changes before memory problems develop.

Recruiting:  Primarily recruiting people with a diagnosis of Parkinson’s who have moderate to severe memory impairment, ages 50 and up.  Also recruiting healthy control subjects, ages 65 and up.

Principal Investigator:  Kathleen Poston, MD, MS.  This study is funded by the Michael J. Fox Foundation for Parkinson’s Research.

Contact:  Anisa Marshall, 650-723-0060

 


2-SU:  Early Differential Diagnosis of Parkinsonism with Metabolic
Imaging and Pattern Analysis

Purpose:  Our goal for this research is to develop imaging markers that will more accurately diagnose parkinsonian disorders, such as Parkinson’s disease, Multiple System Atrophy, Progressive Supranuclear Palsy, and Corticobasal Degeneration.

Principal Investigator:  Kathleen Poston, MD, MS.  This study is funded by the NIH.

Contact:  Hadar Keren-Gille, 650-724-4131

 


3-SU:  Sensory Feedback to Improve Freezing of Gait (FOG) in
Parkinson’s disease:  Is an ecologically valid sound more efficacious
than other auditory feedback to improve FOG in PD?

Purpose:  Testing sensory feedback (quantitative digitography, quantitative wrist flexion/extension, computerized dynamic
posturography and stepping in place both on and off medications, and for those with DBS before and after surgery) to study improvements in freezing of gait, postural control, reaction time and rhythmicity, determined via UPDRS.

Principal Investigator:  Helen Bronte-Stewart, MD, MSE

Contact:  Lauren A. Shreve, 650-855-4656

 


4-SU:  Is Freezing of Gait (FOG) also manifest in movements of the upper extremities?

Purpose:  Testing sensory feedback (quantitative digitography, quantitative wrist flexion/extension, computerized dynamic
posturography and stepping in place both on and off medications, and for those with DBS before and after surgery) to study improvements in freezing of gait, postural control, reaction time and rhythmicity, determined via UPDRS with a particular focus on the upper extremities.

Principal Investigator: Helen Bronte-Stewart, MD, MSE

Contact:  Lauren A. Shreve, 650-855-4656

 

THE PARKINSON’S INSTITUTE AND CLINICAL CENTER

You can always find a list of “actively recruiting” clinical trials and studies here.


1-TPI:   DISCOVERY-PD

Proteomics, Metabolomics, Lipidomics and Genetic Analysis for Biomarker DISCOVERY in Parkinson’s Disease.

Webpage

Contact:  The PI’s clinical trials office voicemail 408-542-5608 or email trials@thepi.org

 


2-TPI:  iSTEP

A Phase 3, 12-week, Double-Blind, Placebo-Controlled, Randomized, Multicenter Study to Evaluate the Efficacy of Oral Istradefylline 20 and 40 mg/day as Treatment for Subjects with Moderate to Severe Parkinson’s Disease

Webpage

Contact:  The PI’s clinical trials office voicemail 408-542-5608 or email trials@thepi.org

 


3-TPI:  The Parkinson’s Progression Markers Initiative (PPMI) – Smell loss

Purpose:  The Parkinson’s Progression Markers Initiative (PPMI) is an international observational study designed to help define biomarkers, or indicators of Parkinson’s disease (PD) progression.  People who are over the age of 60 AND who do not have Parkinson’s are needed for this study that will assess the relationship between Parkinson’s and sense of smell.

Webpage to determine eligibility by taking the smell survey or call 877-525-PPMI

 


4-TPI:  The Parkinson’s Progression Markers Initiative (PPMI) – Genetics

Purpose:  The Parkinson’s Progression Markers Initiative (PPMI) is an international observational study designed to help define biomarkers, or indicators of Parkinson’s disease (PD) progression.  PPMI seeks to enroll individuals with and without PD who carry a genetic mutation in the LRRK2 or SNCA gene.

Webpage

 

UNIVERSITY OF CALIFORNIA BERKELEY


1-UCB:  Functional MRI Study

Purpose: Functional magnetic resonance imaging (fMRI) experiment to examine working memory systems in PD.

Recruiting:  Currently seeking healthy controls 55-75 years of age, but especially males in their early 60s.

Principal Investigators:  Rob White MD, PhD, and Mark D’Esposito, MD

Contact:  berkeleyneuroresearch@gmail.com or phone 415-691-7658

 

UNIVERSITY OF CALIFORNIA DAVIS


1- UCD:  A Clinical Study of Patients With Symptomatic NOH to Assess
Sustained Effects of Droxidopa Therapy

Recruiting Parkinson’s Disease, Multiple System Atrophy, parkinsonism, etc. with symptomatic neurogenic orthostatic hypotension (NOH).

Webpage

Principal Investigator:  Lin Zhang, MD, PhD.

Sponsored by Chelsea Therapeutics.

Contact:  Virina De Jesus, CCRP, senior clinical research coordinator, phone 916-703-9174

Filed Under: Support Groups - Meetings & Notes

  • Home

Categories

  • Monthly List – PD Webinars
  • Webinars – Announcements & Notes
  • Monthly List – Caregiving Webinars
  • Monthly List – Support Groups
  • Support Groups – Meetings & Notes
  • News
  • Research
  • Events
  • Exercise
  • Comment

Top Pages of the Stanford Parkinson’s Community Outreach Website

  • List of Live, Virtual PD Exercise Classes
  • List of PD Exercise Videos
  • Symptoms of PD
  • For Those Newly Diagnosed
  • Support Resources for PD

Featured Posts

Your top three Parkinson’s questions answered by the APDA

The American Parkinson Disease Association (APDA) recently shared the top three questions they are … [Read More...]

National Day of Action – Thursday, September 22, 2022

From the American Parkinson Disease Association, Northwest Chapter (APDA NW), Tuesday, September … [Read More...]

APDA hosting a FREE Virtual Parkinson’s Education Conference Feb. 15-16, 2023

The two-day APDA Virtual Parkinson’s Conference: Educate, Empower, Engage will be geared towards … [Read More...]

Archive

  • March 2023 (7)
  • February 2023 (5)
  • January 2023 (4)
  • December 2022 (7)
  • November 2022 (4)
  • October 2022 (9)
  • September 2022 (2)
  • August 2022 (3)
  • July 2022 (5)
  • June 2022 (6)
  • May 2022 (9)
  • April 2022 (5)
  • March 2022 (8)
  • February 2022 (5)
  • January 2022 (13)
  • December 2021 (7)
  • November 2021 (19)
  • October 2021 (14)
  • September 2021 (12)
  • August 2021 (9)
  • July 2021 (7)
  • June 2021 (10)
  • May 2021 (10)
  • April 2021 (16)
  • March 2021 (8)
  • February 2021 (27)
  • January 2021 (18)
  • December 2020 (18)
  • November 2020 (19)
  • October 2020 (13)
  • September 2020 (7)
  • August 2020 (12)
  • July 2020 (15)
  • June 2020 (13)
  • May 2020 (17)
  • April 2020 (14)
  • March 2020 (14)
  • February 2020 (5)
  • January 2020 (12)
  • December 2019 (10)
  • November 2019 (6)
  • October 2019 (6)
  • September 2019 (7)
  • August 2019 (5)
  • July 2019 (10)
  • June 2019 (3)
  • May 2019 (8)
  • April 2019 (10)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (12)
  • December 2018 (2)
  • November 2018 (8)
  • October 2018 (10)
  • September 2018 (2)
  • August 2018 (7)
  • July 2018 (10)
  • June 2018 (9)
  • May 2018 (3)
  • April 2018 (10)
  • March 2018 (4)
  • February 2018 (8)
  • January 2018 (11)
  • December 2017 (11)
  • November 2017 (5)
  • October 2017 (11)
  • September 2017 (10)
  • August 2017 (7)
  • July 2017 (13)
  • June 2017 (10)
  • May 2017 (14)
  • April 2017 (12)
  • March 2017 (17)
  • February 2017 (11)
  • January 2017 (13)
  • December 2016 (4)
  • November 2016 (6)
  • October 2016 (1)
  • September 2016 (11)
  • August 2016 (5)
  • July 2016 (8)
  • June 2016 (4)
  • May 2016 (2)
  • April 2016 (2)
  • March 2016 (1)
  • February 2016 (1)
  • January 2016 (4)
  • December 2015 (1)
  • November 2015 (2)
  • October 2015 (3)
  • September 2015 (1)
  • August 2015 (3)
  • July 2015 (1)
  • June 2015 (1)
  • May 2015 (1)
  • April 2015 (2)
  • March 2015 (4)
  • February 2015 (2)
  • January 2015 (1)
  • December 2014 (1)
  • November 2014 (2)
  • October 2014 (1)
  • September 2014 (2)
  • August 2014 (2)
  • July 2014 (1)
  • June 2014 (5)
  • May 2014 (1)
  • April 2014 (2)
  • March 2014 (3)
  • February 2014 (1)
  • January 2014 (1)
  • December 2013 (1)
  • November 2013 (1)
  • October 2013 (1)
  • September 2013 (1)
  • August 2013 (1)